Loss of cannabinoid CB1 receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington’s disease

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Neurotoxicity research

• Publication date

  2002-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/10298420290030514
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects.

  2002cited by this paper
• Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease

  2002cited by this paper
• Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease.

  2002cited by this paper
• Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease

  2001cited by this paper
• Localization of cannabinoid CB1 receptor mRNA in neuronal subpopulations of rat striatum: A double‐label in situ hybridization study

  2000cited by this paper
• Effects of systemic 3-nitropropionic acid-induced lesions of the dorsal striatum on cannabinoid and µ-opioid receptor binding in the basal ganglia

  2000cited by this paper
• The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.

  2000cited by this paper
• Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study.

  2000cited by this paper
• Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice.

  2000cited by this paper
• Recent advances in understanding the pathogenesis of Huntington's disease.

  1999cited by this paper
• Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide.

  1999cited by this paper
• Advances in Huntington's disease: implications for experimental therapeutics.

  1998cited by this paper
• Brain cannabinoid systems as targets for the therapy of neurological disorders.

  1998cited by this paper
• 3‐Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration

  1998cited by this paper
• Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system.

  1998cited by this paper
• Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease.

  1998cited by this paper
• A novel effect of nicotine on mood and sleep in major depression

  1998cited by this paper
• Recent advances in Huntington's disease: implications for experimental therapeutics

  1998influential reference
• Hyperactivity and hypoactivity in a rat model of Huntington's disease: the systemic 3-nitropropionic acid model.

  1997cited by this paper
• Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function.

  1995cited by this paper
• Measurement of GABA in rat brain microdialysates using o-phthaldialdehyde-sulphite derivatization and high-performance liquid chromatography with electrochemical detection.

  1994cited by this paper
• Selective vulnerability in Huntington's disease: Preferential loss of cannabinoid receptors in lateral globus pallidus

  1994cited by this paper
• Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study.

  1994cited by this paper
• Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

  1993cited by this paper
• Loss of cannabinoid receptors in the substantia nigra in Huntington's disease.

  1993cited by this paper
• Age‐Dependent Vulnerability of the Striatum to the Mitochondrial Toxin 3‐Nitropropionic Acid

  1993cited by this paper
• Neuron-specific enolase (NSE) and non-neuronal enolase (NNE) mRNAs are co-expressed in neurons of the rat cerebellum: in situ hybridization histochemistry.

  1993cited by this paper
• Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry.

  1992cited by this paper
• Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

  1991cited by this paper
• Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.

  1991cited by this paper
• Huntington's disease

  1991cited by this paper
• Maps and guide to microdissection of the rat brain

  1988cited by this paper
• Differential loss of striatal projection neurons in Huntington disease.

  1988cited by this paper
• Maps and guide to microdissection of the rat brain

  1988cited by this paper
• Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.

  1986cited by this paper
• Neuropathological Classification of Huntington's Disease

  1985cited by this paper
• Effects of Repeated Administration of Estradiol Benzoate on Tubero‐Infundibular GABAergic Activity in Male Rats

  1985cited by this paper
• Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing

  1984cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography.

  1979cited by this paper

• Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington’s disease models

  2025cites this paper
• The globus pallidus as a target for neuropeptides and endocannabinoids participating in central activities.

  2019cites this paper
• The Endocannabinoid System in Prefrontal Synaptopathies

  2017cites this paper
• Cannabis for Basal Ganglia Disorders (Parkinson Disease and Huntington Disease)

  2017cites this paper
• Antiepileptic and Neuroprotective Effects of Oleamide in Rat Striatum on Kainate-Induced Behavioral Seizure and Excitotoxic Damage via Calpain Inhibition

  2017cites this paper
• The Endocannabinoid System and Human Brain Functions: Insight From Memory, Motor, and Mood Pathologies

  2017cites this paper
• Type-2 cannabinoid receptors in neurodegeneration.

  2016cites this paper
• The bright side of psychoactive substances: cannabinoid-based drugs in motor diseases

  2016cites this paper
• Conclusions: Therapeutic Potential of Novel Cannabinoid Receptors

  2013cites this paper
• CANNABINOIDS REGULATE TYPE 1 CANNABINOID RECEPTOR EXPRESSION IN CELL CULTURE MODELS OF HUNTINGTON'S DISEASE

  2012cites this paper
• Cannabinoids: novel medicines for the treatment of Huntington's disease.

  2012cites this paper
• Brain networks in Huntington disease.

  2011cites this paper
• Huntington’s Disease and Group I Metabotropic Glutamate Receptors

  2011cites this paper
• Synaptic Dysfunction in Huntington’s Disease

  2011cites this paper
• 3-Nitropropionic Acid as a Tool to Study the Mechanisms Involved in Huntington’s Disease: Past, Present and Future

  2010cites this paper
• Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases

  2009influential citation
• Neurokinin-1 Receptor Activation in Globus Pallidus

  2009cites this paper
• Role of endocannabinoid system in mental diseases

  2009cites this paper
• The endocannabinoid system as a target for the treatment of motor dysfunction

  2009influential citation
• Gene-environment interplay in neurogenesis and neurodegeneration

  2009cites this paper
• The therapeutic potential of novel cannabinoid receptors.

  2009cites this paper
• The Endocannabinoid System in the Physiology and Pathology of the Basal Ganglia

  2008cites this paper
• The endocannabinoid system in Huntington's disease.

  2008cites this paper
• Cannabinoids and the brain

  2008cites this paper